⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NBTX News
Nanobiotix S.A. American Depositary Shares
Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology
globenewswire.com
NBTX
Voting Rights and Shares Capital of the Company
globenewswire.com
NBTX
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
globenewswire.com
NBTX
NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
globenewswire.com
NBTX
JNJ
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026
globenewswire.com
NBTX
NANOBIOTIX Statement Regarding Recent Media Speculation
globenewswire.com
NBTX
Voting Rights and Shares Capital of the Company
globenewswire.com
NBTX
NANOBIOTIX to Participate in Investor Conferences in March
globenewswire.com
NBTX
Voting Rights and Shares Capital of the Company
globenewswire.com
NBTX
Voting Rights and Shares Capital of the Company
globenewswire.com
NBTX